The Half-Life-Extended IL21 can Be Combined With Multiple Checkpoint Inhibitors for Tumor Immunotherapy

Overview of attention for article published in Frontiers in Cell and Developmental Biology, November 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter: 3 X users

patent: 1 patent

Citations

dimensions_citation: 15 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

IL-21 FUSION PROTEINS USEFUL AS ENHANCERS OF ANTI-CANCER IMMUNOTHERAPIES

Application WO-2024062047-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.